Trials / Sponsors / EPS Corporation
EPS Corporation
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC Colorectal Neoplasms | Phase 2 | 2014-05-01 |
| Completed | Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Rese Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer | Phase 2 | 2013-05-01 |
| Completed | Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection f Liver Metastasis, Colorectal Cancer | N/A | 2013-05-01 |